GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » EV-to-EBITDA

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) EV-to-EBITDA

: 21.39 (As of Today)
View and export this data going back to . Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Carl Zeiss Meditec AG's enterprise value is $9,473 Mil. Carl Zeiss Meditec AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $443 Mil. Therefore, Carl Zeiss Meditec AG's EV-to-EBITDA for today is 21.39.

The historical rank and industry rank for Carl Zeiss Meditec AG's EV-to-EBITDA or its related term are showing as below:

CZMWF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.07   Med: 24.41   Max: 57.8
Current: 21.06

During the past 13 years, the highest EV-to-EBITDA of Carl Zeiss Meditec AG was 57.80. The lowest was 10.07. And the median was 24.41.

CZMWF's EV-to-EBITDA is ranked worse than
68.85% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 14.625 vs CZMWF: 21.06

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-20), Carl Zeiss Meditec AG's stock price is $97.95. Carl Zeiss Meditec AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.338. Therefore, Carl Zeiss Meditec AG's PE Ratio for today is 29.34.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Carl Zeiss Meditec AG EV-to-EBITDA Historical Data

The historical data trend for Carl Zeiss Meditec AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.85 36.48 36.82 19.39 15.08

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.36 28.50 19.54 15.08 21.49

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's EV-to-EBITDA falls into.



Carl Zeiss Meditec AG EV-to-EBITDA Calculation

Carl Zeiss Meditec AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9472.787/442.834
=21.39

Carl Zeiss Meditec AG's current Enterprise Value is $9,473 Mil.
Carl Zeiss Meditec AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $443 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Carl Zeiss Meditec AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=97.95/3.338
=29.34

Carl Zeiss Meditec AG's share price for today is $97.95.
Carl Zeiss Meditec AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.338.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Carl Zeiss Meditec AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.